Psychotherapy for patients with metastatic cancer in Chile
Preliminary Efficacy and Acceptability of CALM Psychotherapy in Chile
NA · Fundacion Arturo Lopez Perez · NCT06501261
This study is testing a new online therapy program to help people in Chile with metastatic cancer cope with their emotional distress.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundacion Arturo Lopez Perez (other) |
| Locations | 1 site (Providencia, Santiago Metropolitan) |
| Trial ID | NCT06501261 on ClinicalTrials.gov |
What this trial studies
This study evaluates the CALM psychotherapy program, which is designed to address the emotional distress experienced by patients with metastatic cancer. The intervention consists of 3 to 6 individual psychotherapy sessions, conducted over a period of 3 to 6 months, with the option for a caregiver to participate in some sessions. The study aims to assess the preliminary efficacy of this evidence-based approach in a sample of 34 patients in Chile, where there is a lack of effective therapeutic interventions for this population. Sessions will be conducted online and may be recorded for supervision and training purposes.
Who should consider this trial
Good fit: Ideal candidates are Spanish-speaking adults aged 18 and older with a diagnosis of advanced or metastatic solid tumor cancer and a life expectancy greater than six months.
Not a fit: Patients with significant verbal communication difficulties, cognitive impairments, or those currently undergoing psychotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this psychotherapy could significantly improve the emotional well-being of patients with metastatic cancer.
How similar studies have performed: While this approach is based on established evidence from the Global CALM program, the specific application in Chile is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * be ≥18 years of age; * be fluent in Spanish; * be able to give informed consent; and * have received a diagnosis of advanced or metastatic solid tumor cancer with a reduced life expectancy but greater than six months. Exclusion Criteria: * significant verbal communication difficulties; * cognitive impairment indicated by the clinical team or in the patient's file. * Patients currently in psychotherapy. * Active suicidal ideation
Where this trial is running
Providencia, Santiago Metropolitan
- Fundacion Arturo Lopez Perez — Providencia, Santiago Metropolitan, Chile (RECRUITING)
Study contacts
- Principal investigator: Loreto Fernandez-Gonzalez — Fundacion Arturo Lopez Perez
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Metastatic Cancer, psychotherapy, palliative care